{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:08:57Z","timestamp":1792642137667,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T00:00:00Z","timestamp":1243209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T00:00:00Z","timestamp":1243209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/bmt.2009.97","type":"journal-article","created":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T10:44:31Z","timestamp":1243248271000},"page":"149-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"45","author":[{"given":"E","family":"Peres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y A","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R B","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O I","family":"Krijanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mineishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,25]]},"reference":[{"key":"BFbmt200997_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1470-2045(00)00153-4","volume":"1","author":"C Craddock","year":"2000","unstructured":"Craddock C . Haemopoietic stem cell transplantation: recent progress and future promise. Lancet Oncol 2000; 1: 227\u2013234.","journal-title":"Lancet Oncol"},{"key":"BFbmt200997_CR2","first-page":"173","volume":"5","author":"SI Bearman","year":"1990","unstructured":"Bearman SI, Petersen FB, Schor RA, Denney JD, Fisher LD, Appelbaum FR et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant 1990; 5: 173\u2013177.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200997_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1200\/JCO.1991.9.7.1215","volume":"9","author":"AC Braverman","year":"1991","unstructured":"Braverman AC, Antin JH, Plappert MT, Cooke EF, Lee RT . Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 1991; 9: 1215\u20131223.","journal-title":"J Clin Oncol"},{"key":"BFbmt200997_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/sj.bmt.1702234","volume":"25","author":"BE Brockstein","year":"2000","unstructured":"Brockstein BE, Smiley C, Al-Sadir J, Williams SF . Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant 2000; 25: 885\u2013894.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200997_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","volume":"27","author":"K Fujimaki","year":"2001","unstructured":"Fujimaki K, Maruta A, Yoshida M, Sakai R, Tanabe J, Koharazawa H et al. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant 2001; 27: 307\u2013310.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200997_CR6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","volume":"68","author":"MA Goldberg","year":"1986","unstructured":"Goldberg MA, Antin JH, Guinan EC, Rappeport JM . Cyclophosphamide cardiotoxicity an analysis of dosing as a risk factor. Blood 1986; 68: 1114\u20131118.","journal-title":"Blood"},{"key":"BFbmt200997_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1200\/JCO.1994.12.5.998","volume":"12","author":"B Hertenstein","year":"1994","unstructured":"Hertenstein B, Stefanic M, Schmeiser T, Scholz M, Goller V, Clausen M et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12: 998\u20131004.","journal-title":"J Clin Oncol"},{"key":"BFbmt200997_CR8","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","volume":"57","author":"B Cazin","year":"1986","unstructured":"Cazin B, Gorin NC, Laporte JP, Gallet B, Douay L, Lopez M et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer 1986; 57: 2061\u20132069.","journal-title":"Cancer"},{"key":"BFbmt200997_CR9","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/sj.bjc.6601001","volume":"88","author":"JG Schrama","year":"2003","unstructured":"Schrama JG, Holtkamp MJ, Baars JW, Schornagel JH, Rodenhuis S . Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute Experience. Br J Cancer 2003; 88: 1831\u20131838.","journal-title":"Br J Cancer"},{"key":"BFbmt200997_CR10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushniky Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BFbmt200997_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0140-6736(76)90151-3","volume":"1","author":"F Appelbaum","year":"1976","unstructured":"Appelbaum F, Strauchen JA, Graw RG, Savage DD, Kent KM, Ferrans VJ et al. Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet 1976; 1: 58\u201362.","journal-title":"Lancet"},{"key":"BFbmt200997_CR12","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/cncr.2820360904","volume":"36","author":"GM Mullins","year":"1975","unstructured":"Mullins GM, Anderson PN, Antos GW . High-dose cyclophosphamide therapy in solid tumors. Therapeutic, toxic and immunosuppressive effects. Cancer 1975; 36: 1950\u20131958.","journal-title":"Cancer"},{"key":"BFbmt200997_CR13","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/1097-0142(197906)43:6<2223::AID-CNCR2820430610>3.0.CO;2-Y","volume":"43","author":"BA Mills","year":"1979","unstructured":"Mills BA, Roberts RW . Cyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literature. Cancer 1979; 43: 2223\u20132226.","journal-title":"Cancer"},{"key":"BFbmt200997_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","volume":"141","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J . Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 1981; 141: 758\u2013763.","journal-title":"Arch Intern Med"},{"key":"BFbmt200997_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631\u2013637.","journal-title":"Blood"},{"key":"BFbmt200997_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/sj.bmt.1701217","volume":"21","author":"A Olivieri","year":"1998","unstructured":"Olivieri A, Corvatta L, Montanari M, Brunori M, Offidani M, Ferretti GF et al. Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. Bone Marrow Transplant 1998; 21: 1049\u20131053.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200997_CR17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.bmt.1701763","volume":"23","author":"P Moreau","year":"1999","unstructured":"Moreau P, Milpied N, Mahe B, Juge-Marineau N, Rapp MJ, Bataille R et al. Melphalan 220\u2009mg\/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma. Bone Marrow Transplant 1999; 23: 1003\u20131006.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200997_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mpo.2950090502","volume":"9","author":"LJ Steinherz","year":"1981","unstructured":"Steinherz LJ, Steinherz PG, Mangiacasale D, O'Reilly R, Allen J, Sorell M et al. Cardiac changes with cyclophosphamide. Med Pediatr Oncol 1981; 9: 417\u2013422.","journal-title":"Med Pediatr Oncol"},{"key":"BFbmt200997_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/annonc\/mdf167","volume":"13","author":"LC Kremer","year":"2002","unstructured":"Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA . Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 2002; 13: 819\u2013829.","journal-title":"Ann Oncol"},{"key":"BFbmt200997_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1083-8791(00)70043-7","volume":"6","author":"Y Nieto","year":"2000","unstructured":"Nieto Y, Cagnoni PJ, Bearman SI, Shpall EJ, Matthes S, Jones RB . Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. Biol Blood Marrow Transplant 2000; 6: 198\u2013203.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt200997_CR21","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/cncr.11407","volume":"97","author":"SM Swain","year":"2003","unstructured":"Swain SM, Whaley FS, Ewer MS . Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003; 97: 2869\u20132879.","journal-title":"Cancer"},{"key":"BFbmt200997_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.bmt.1704166","volume":"32","author":"K Van Besien","year":"2003","unstructured":"Van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M et al. Regimen-related toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies. Bone Marrow Transplant 2003; 32: 471\u2013476.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200997_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1046\/j.1365-2141.2001.03153.x","volume":"115","author":"R Martino","year":"2001","unstructured":"Martino R, Caballero MD, Canals C, Simon JA, Solano C, Urvano-Ispizua A et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. Br J Haematol 2001; 115: 653\u2013659.","journal-title":"Br J Haematol"},{"key":"BFbmt200997_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2165\/00003495-199142050-00005","volume":"42","author":"LH Fraiser","year":"1991","unstructured":"Fraiser LH, Kanekal S, Kehrer JP . Cyclophosphamide toxicity: characterising and avoiding the problem. Drugs 1991; 42: 781\u2013795.","journal-title":"Drugs"},{"key":"BFbmt200997_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbmt.2004.03.001","volume":"10","author":"GL Phillips","year":"2004","unstructured":"Phillips GL, Meisenberg B, Reece DE, Adams VR, Badros A, Brunner J et al. Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study. Biol Blood Marrow Transplant 2004; 10: 473\u2013483.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt200997_CR26","first-page":"218","volume":"79","author":"M Spriano","year":"1994","unstructured":"Spriano M, Clavio M, Carrara P, Canepa L, Miglino M, Pierri I et al. Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. Haematologica 1994; 79: 218\u2013224.","journal-title":"Haematologica"},{"key":"BFbmt200997_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bmt.1703098","volume":"28","author":"DS Ritchie","year":"2001","unstructured":"Ritchie DS, Seymour JF, Roberts AW, Szer J, Grigg AP . Acute left ventricular failure following melphalan and fludarabine conditioning. Bone Marrow Transplant 2001; 28: 101\u2013103.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt200997_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/annonc\/mdf132","volume":"13","author":"BV Jensen","year":"2002","unstructured":"Jensen BV, Skovsgaard T, Nielsen SL . Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients. Ann Oncol 2002; 13: 699\u2013709.","journal-title":"Ann Oncol"},{"key":"BFbmt200997_CR29","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","volume":"48","author":"N Kalay","year":"2006","unstructured":"Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A et al. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 2006; 48: 2258\u20132262.","journal-title":"J Am Coll Cardiol"},{"key":"BFbmt200997_CR30","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1200\/JCO.2008.17.7428","volume":"26","author":"SH Armenian","year":"2008","unstructured":"Armenian SH, Sun CL, Francisco L, Steinberger J, Kurian S, Wong FL et al. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol 2008; 26: 5537\u20135543.","journal-title":"J Clin Oncol"},{"key":"BFbmt200997_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/clc.4960211017","volume":"21","author":"S Fazio","year":"1998","unstructured":"Fazio S, Palmieri EA, Ferravante B, Bone F, Biondi B, Facca L . Doxorubicin-induced cardiomyopathy treated with carvedilol. Clin Cardiol 1998; 21: 777\u2013779.","journal-title":"Clin Cardiol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt200997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt200997","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt200997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:18:50Z","timestamp":1648037930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt200997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFbmt200997"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2009.97","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,25]]},"assertion":[{"value":"13 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}